How we rate providers: Transparent, patient-first scoring →
Gala GLP-1 homepage showing GLP-1 weight loss services

Gala GLP-1

Gala GLP-1 homepage showing GLP-1 weight loss services
Gala GLP-1
Our Review
Gala GLP-1 earns a 3.5 out of 5 from GLP-1.Reviews, placing it in the middle tier of providers we have evaluated. Its competitive pricing and solid Trustpilot reviews are genuine strengths, while the F BBB rating and developing support infrastructure are areas for improvement. This provider is a reasonable choice for patients who prioritize affordability and are comfortable with a newer platform that is still maturing its operations.
Clinical Quality
Support
Patient Protection
Cost & Value
Access
Trust & Transparency
Authenticity
Reputation
Reader Rating0 Votes
What We Like
4.4 Trustpilot across 975+ reviews
Competitive pricing $199-$299/mo
Both semaglutide and tirzepatide
Nationwide telehealth
What Could Be Better
F BBB rating
No lab testing or dietitian
Compounded only, unknown CoA
No insurance accepted
3.5
Competitive but Mixed
💊
Medications
Compounded Semaglutide, Compounded Tirzepatide
💰
Monthly Cost
$199-$299/mo

Speed to Start
Fast

Trustpilot
4.4 / 5 (975+ reviews)
✓ Verified Provider
Compounded Medications
Est. 2023

About Gala GLP-1

Gala GLP-1 is a 2023-founded telehealth provider offering compounded semaglutide and tirzepatide at prices between $199 and $299 per month. The company entered a crowded market but has built a modest following with competitive pricing and a straightforward enrollment process. Gala positions itself as an accessible option for patients who want GLP-1 therapy without the premium pricing charged by larger platforms.

The pricing structure is one of Gala’s more attractive features. With a 9 ceiling on monthly costs, the platform avoids the sticker shock that some competitors create with tiered plans reaching ,000 or more. Both semaglutide and tirzepatide are available as compounded formulations, giving patients the option to try either GLP-1 receptor agonist pathway. The onboarding process includes a medical intake and asynchronous provider review, which is standard for the category.

On Trustpilot, Gala GLP-1 holds a 4.4-star rating from 975+ reviews, a respectable score that suggests generally positive patient experiences. The review count is growing, and the rating has remained stable as volume increases, which is a positive signal. Common praise points include medication effectiveness and reasonable pricing. Complaints tend to center on shipping delays and communication gaps during the fulfillment process.

The company’s F rating with the BBB is a concern, though as noted throughout our reviews, BBB ratings in the telehealth GLP-1 space are frequently poor across the board. The F grade appears driven by complaint volume relative to the company’s size and unresolved disputes. Support is moderate, with Gala offering some level of ongoing patient communication but falling short of the comprehensive check-in protocols that top-tier providers maintain.

Gala GLP-1 is a growing provider still establishing its operational maturity. The fundamentals are reasonable: competitive pricing, both major GLP-1 compounds available, and solid Trustpilot feedback. The question is whether the company can scale its support infrastructure to match its patient growth. For now, it occupies a middle position in our rankings, neither a standout nor a concern, but a viable option for price-sensitive patients willing to accept some operational rough edges.

At a Glance

Medications Offered

Compounded Semaglutide, Compounded Tirzepatide

Compounded

Cost & Insurance

  • Monthly: $199-$299/mo
  • 6-month estimate: $1,194-$1,794
  • Insurance: No
  • Self-pay: Yes

Clinical Features

  • Lab testing: No
  • Dietitian access: No
  • Verified Pharmacy: Third-party partner pharmacy handles prescribing/dispensing/delivery; specific pharmacy not named
  • BBB Rating: F

Delivery & Access

  • Format: Subcutaneous
  • Nationwide telehealth: Yes
  • Speed: Fast
  • Spanish-speaking providers: Not available
Visit Gala GLP-1 →

Start your GLP-1 weight loss journey with Gala GLP-1 today

Medical Disclaimer: This review is for informational purposes only and does not constitute medical advice. GLP-1 medications are prescription drugs that should only be used under the supervision of a licensed healthcare provider. Individual results may vary.

Editorial Independence: GLP-1.Reviews maintains full editorial independence. Our scores are based on verified data and standardized criteria.

From the Inside

What the Gala GLP-1 Intake Looks Like

We walked through the Gala GLP-1 intake ourselves, from the opening goal question through a detailed 42-screen medical history, a LegitScript-Certified trust slide, and finally a three-plan Stripe-powered checkout. The safety screens are notably thorough and Gala is one of the few platforms we’ve audited that surfaces a LegitScript certification badge in the flow.

42
Total Screens
~6 min
Time to Complete
9
Distinct Stages
Clinical Rigor
8/ 10

Wide and specific safety net. Eating disorder, suicidal OR homicidal thoughts, cancer with a 5-year remission rule, pancreatitis, warfarin, QT prolongation, Stage 3A+ kidney disease, and a combined thyroid cyst/nodule/cancer/MTC/MEN-2 screen. LegitScript certification surfaced in the flow.

Friction Level
5/ 10

Moderate. 42 screens is longer than the category median, but the pace is fast and the default 3-month plan lands at $199/mo after a $300 discount. Explicit auto-renewal consent on screen 3 — read the subscription language carefully.

The 9 Stages

Stage 1
Goals & Consent
Weight-loss goal (1-15 / 16-50 / 51+ / not sure), a “92% of Gala customers aiming to lose 16-50 lbs choose GLP-1 injections” social proof slide, state selection with Terms and Conditions AND an explicit auto-renewal subscription consent
Stage 2
Demographics & BMI
Date of birth, sex at birth (Female/Male), height, weight, desired weight, and a “Lose up to 20% of your weight” projection chart citing clinical studies at 3, 6, and 12 months
Stage 3
Journey & Lifestyle
Previous weight-loss programs tried (none / 1-5 / 6-10 / more than I can remember), motivation multi-select, willingness to reduce calories and/or increase physical activity, weight change in the last 12 months, and currently or recently taking weight-loss medication
Stage 4
Health History & Comorbidities
An early hard-gate contraindication list (reduced liver function / fatty liver, kidney disease, systolic BP over 180), a weight-related comorbidity multi-select (HTN, lipids, reduced liver function, T2D, CHD / stroke, CHF, osteoarthritis, sleep apnea), and a chronic-diseases multi-select (gallbladder disease, T2D on insulin, T1D, diabetic retinopathy, warfarin use, pancreatitis, Stage 3A+ kidney disease, QT prolongation or heart rhythm disorder)
Stage 5
Self-Reported Vitals
Self-reported blood pressure range with a Stage-2+ tier (<120/80 normal, 120-129 elevated, 130-179 Stage 1-2, 180/120 or higher) and self-reported resting heart rate range (<60 slow, 60-100 normal, 101-110 slightly fast, >110 fast, not sure)
Stage 6
Major Contraindication Multi-Select
Eating disorder, end-stage kidney disease (dialysis), end-stage liver disease (cirrhosis), current suicidal or homicidal thoughts, cancer (active / in treatment / remission less than 5 years, with a non-melanoma skin cancer exception), organ transplant on anti-rejection medication, severe GI condition (gastroparesis / blockage / IBD), and current diagnosis of or treatment for alcohol dependence
Stage 7
Thyroid / MEN Family-or-Personal
“Have you or a family member ever been diagnosed with any of the following conditions?” — thyroid cyst or nodule, thyroid cancer, medullary thyroid carcinoma, and multiple endocrine neoplasia syndrome type 2 (MEN-2) as separate selectable options. Bariatric surgery history, prediabetes / T2D yes/no, a GLP-1 mechanism-of-action education slide
Stage 8
Meds, Allergies, Pharmacy & Attribution
Current prescription medications / vitamins / supplements, personalization preferences multi-select (muscle maintenance, nausea support, longevity, cognitive, energy, hormonal, sleep, “talk to clinician”), additional provider questions, blended ingredients preference, comprehensive allergy prompt, an optional current-pharmacy name and address field, and how the patient first heard about Gala
Stage 9
Plan Review & Checkout
BMI eligibility card (31.50 for the persona, “Medication zone BMI 25-40+”), medication selection between Compounded GLP-1 (Semaglutide) and Compounded GLP-1/GIP (Tirzepatide), a “HIPAA Compliant + LegitScript Certified” trust slide with an explicit “Gala is not affiliated with Novo Nordisk or Eli Lilly” disclaimer, shipping address, and final checkout — 3-month $199/mo (Most Popular, $300 off, $597 due today), 12-month $179/mo (Best Value), or monthly $299/mo. Stripe-powered with a full refund if not eligible

Clinical Safety Screens Performed

Eating disorder — current or prior
Suicidal OR homicidal thoughts
Alcohol dependence — current treatment
Cancer — 5-year rule with skin-cancer exception
MTC & MEN-2 personal or family history
Thyroid cyst / nodule / cancer — separate options
Pancreatitis personal history
Warfarin blood thinner use
QT prolongation / heart rhythm disorder
Stage 3A+ kidney disease
Self-reported BP and resting heart rate
Comprehensive allergy prompt + current pharmacy field
🛡 LegitScript Certified Badge Surfaced In-Flow

Gala is one of the few GLP-1 telehealth intakes in our catalog that surfaces a LegitScript Certified badge directly on the “Your personalized plan is almost ready” screen, alongside a HIPAA Compliant badge. LegitScript is a third-party compliance vendor that audits pharmacies and telehealth platforms — the certification isn’t a substitute for named pharmacy disclosure, but it is a credible trust signal that most peers don’t expose. Gala also prints an explicit disclaimer on the same screen: “Our custom GLP-1 formulations are independently developed and may vary in concentration or ingredients from other branded pens. Gala is not affiliated with Novo Nordisk or Eli Lilly.” That language is more honest than the industry norm.

🧠 Suicidal OR Homicidal Thoughts — Both in One Gate

Gala’s contraindication multi-select includes “Current suicidal/homicidal thoughts” as a single combined option. Suicide risk is rare enough in category intakes; the homicidal ideation pairing is effectively unique in our audit. The gate is broader than the norm, and paired with the eating disorder and alcohol-dependence gates it builds a meaningful mental-health-adjacent safety net without requiring a formal PHQ instrument.

💊 Specific Drug Interaction Screens: Warfarin & QT Prolongation

In addition to a generic “are you on any medications” yes/no, Gala specifically asks whether the patient uses warfarin (Coumadin / Jantoven) and whether they have QT prolongation or another heart rhythm disorder. Warfarin interaction is clinically relevant because GLP-1-induced changes in gastric emptying can alter absorption of narrow-therapeutic-index drugs, and QT prolongation matters because of the cardiac side-effect profile of some weight-loss adjuncts. Most intakes defer these to the live visit. Gala surfaces them as structured gates in the written flow.

💰 Three Plans, Auto-Renewal Consent Up Front

Final checkout is a clean three-card shelf — 3-month plan at $199/mo (Most Popular, $300 off the $299 monthly, $597 due today), 12-month plan at $179/mo (Best Value), or monthly at $299/mo. The checkout is Stripe-powered with 256-bit SSL encryption and a “full refund if not eligible” guarantee. Worth noting: back on screen 3, Gala requires an explicit auto-renewal subscription consent — the patient acknowledges up front that each month auto-renews unless cancelled, and that first-month charges happen after provider review. Patients should read that consent line carefully rather than checking it on autopilot.

⚠ What the Gala Intake Doesn’t Ask

The intake does not use a validated PHQ-2 or PHQ-9 depression instrument (mental health is covered by the suicidal/homicidal and eating disorder gates), does not split personal vs family history into separate questions on MTC or MEN-2 (they’re combined in a single “you or a family member” prompt), and does not include a dedicated opioid or broader substance-use screen beyond alcohol dependence. There is no ID upload and no phone OTP.

Source: GLP-1.Reviews editorial walkthrough on April 13, 2026. We completed every screen of the Gala GLP-1 intake using a representative GLP-1 candidate persona and stopped before submitting any payment information.

Visit Gala GLP-1 →

Opens galaglp1.com in a new tab. We may earn a commission if you start treatment through this link, at no additional cost to you.

Gala GLP-1
3.5 / 5.0
Competitive

Let's Review Widget